StacieShepherdMDPhD

Clinical Trials

• Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor Start of enrollment: 2010 Mar 01

  Completed

  Phase 1

• Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2011 May 06

  Completed

  Phase 1

• Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer Start of enrollment: 2012 Jan 23

  Completed

  Phase 2

• A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors Start of enrollment: 2013 Nov 01

  Completed

  Phase 1

• A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors Start of enrollment: 2013 Dec 01

  Completed

  Phase 1

• A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer Start of enrollment: 2014 Jul 17

  Completed

  Phase 3

• CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Start of enrollment: 2017 Sep 21

  Completed

  Phase 1

• Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC Start of enrollment: 2017 Dec 15

  Completed

  Phase 1, Phase 2

• Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Start of enrollment: 2020 Jun 30

  Terminated

  Phase 3

• Join now to see all